Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Ratios and Metrics

Market cap in millions RUB. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 7, 2022	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,287	-	4,401	4,419	4,287	8,272
Market Cap Growth	-	-	-0.41%	3.10%	-48.18%	201.10%
Enterprise Value	4,936	-	5,317	5,296	5,060	8,928
Last Close Price	59.54	-	59.54	59.54	59.54	114.90
PE Ratio	46.16	-	20.48	26.17	92.95	711.21
PS Ratio	2.50	-	2.89	3.23	3.77	7.01
PB Ratio	3.76	-	4.10	4.53	7.52	17.96
P/TBV Ratio	-	-	74.03	17.75	22.45	77.90
P/FCF Ratio	210.58	-	11.52	19.17	50.80	64.88
P/OCF Ratio	22.47	-	9.13	10.16	19.46	29.46
EV/Sales Ratio	2.88	-	3.50	3.87	4.45	7.56
EV/EBITDA Ratio	19.50	-	15.00	16.32	36.80	47.29
EV/EBIT Ratio	44.48	-	17.75	19.23	51.92	68.45
EV/FCF Ratio	242.47	-	13.91	22.97	59.97	70.02
Debt / Equity Ratio	0.85	0.85	0.69	0.81	1.46	1.34
Debt / EBITDA Ratio	3.46	3.46	1.92	2.27	5.51	2.94
Debt / FCF Ratio	47.41	47.41	1.93	3.41	9.86	4.84
Net Debt / Equity Ratio	0.35	0.35	0.19	0.22	1.06	0.92
Net Debt / EBITDA Ratio	1.43	1.43	0.56	0.66	4.40	2.24
Net Debt / FCF Ratio	19.63	19.63	0.52	0.93	7.17	3.32
Asset Turnover	0.61	0.61	0.58	0.60	0.60	0.73
Inventory Turnover	7.44	7.44	1.86	1.75	1.99	1.93
Quick Ratio	0.94	0.94	1.40	1.30	0.90	0.81
Current Ratio	1.79	1.79	2.29	1.99	1.74	1.77
Return on Equity (ROE)	9.72%	9.72%	23.55%	25.20%	4.48%	7.66%
Return on Assets (ROA)	3.02%	3.02%	7.18%	7.50%	3.22%	5.02%
Return on Invested Capital (ROIC)	8.89%	9.73%	24.34%	21.45%	7.46%	15.53%
Return on Capital Employed (ROCE)	6.20%	6.20%	13.60%	13.90%	5.90%	9.60%
Earnings Yield	2.26%	-	4.88%	3.82%	1.08%	0.14%
FCF Yield	0.47%	-	8.68%	5.22%	1.97%	1.54%
Dividend Yield	-	-	-	2.02%	1.68%	-
Payout Ratio	57.97%	57.97%	65.46%	61.72%	-	-
Buyback Yield / Dilution	-1.06%	18.88%	-	-6.60%	-8.64%	-6.67%
Total Shareholder Return	-1.06%	18.88%	-	-4.58%	-6.96%	-6.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.